-
1
-
-
0020977018
-
Immunobiology of tissue transplantation: A return to the passenger leukocyte concept
-
Laffery KJ, Prowse SJ, Simeonovic CJ, Warren HS. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol. 1983;1: 143-173.
-
(1983)
Annu Rev Immunol.
, vol.1
, pp. 143-173
-
-
Laffery, K.J.1
Prowse, S.J.2
Simeonovic, C.J.3
Warren, H.S.4
-
2
-
-
0024327899
-
Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy
-
Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol. 1989;7:445-480.
-
(1989)
Annu Rev Immunol.
, vol.7
, pp. 445-480
-
-
Mueller, D.L.1
Jenkins, M.K.2
Schwartz, R.H.3
-
3
-
-
84967205692
-
CD28 costimulation: From mechanism to therapy
-
Esensten JH, Helou YA, Chopra G, Weiss A, Bluestone JA. CD28 costimulation: from mechanism to therapy. Immunity. 2016; 44(5):973-988.
-
(2016)
Immunity
, vol.44
, Issue.5
, pp. 973-988
-
-
Esensten, J.H.1
Helou, Y.A.2
Chopra, G.3
Weiss, A.4
Bluestone, J.A.5
-
4
-
-
0026075319
-
The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family
-
Camerini D, Walz G, Loenen WA, Borst J, Seed B. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J Immunol. 1991;147(9):3165-3169.
-
(1991)
J Immunol.
, vol.147
, Issue.9
, pp. 3165-3169
-
-
Camerini, D.1
Walz, G.2
Loenen, W.A.3
Borst, J.4
Seed, B.5
-
5
-
-
0025320534
-
Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes-A molecule related to nerve growth factor receptor
-
Mallett S, Fossum S, Barclay AN. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes-a molecule related to nerve growth factor receptor. EMBO J. 1990;9(4):1063-1068.
-
(1990)
EMBO J.
, vol.9
, Issue.4
, pp. 1063-1068
-
-
Mallett, S.1
Fossum, S.2
Barclay, A.N.3
-
6
-
-
85014339020
-
TIGIT and CD96: New checkpoint receptor targets for cancer immunotherapy
-
Dougall WC, Kurtulus S, Smyth MJ, Anderson AC. TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy. Immunol Rev. 2017;276(1):112-120.
-
(2017)
Immunol Rev.
, vol.276
, Issue.1
, pp. 112-120
-
-
Dougall, W.C.1
Kurtulus, S.2
Smyth, M.J.3
Anderson, A.C.4
-
8
-
-
84967103686
-
The TNF receptor superfamily in costimulating and co-inhibitory responses
-
Ward-Kavanagh LK, Lin WW, Šedý JR, Ware CF. The TNF receptor superfamily in costimulating and co-inhibitory responses. Immunity. 2016;44(5):1005-1019.
-
(2016)
Immunity
, vol.44
, Issue.5
, pp. 1005-1019
-
-
Ward-Kavanagh, L.K.1
Lin, W.W.2
Šedý, J.R.3
Ware, C.F.4
-
9
-
-
0029120245
-
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
-
Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med. 1995; 182(2):459-465.
-
(1995)
J Exp Med.
, vol.182
, Issue.2
, pp. 459-465
-
-
Krummel, M.F.1
Allison, J.P.2
-
10
-
-
85015679329
-
Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent
-
Kamphorst AO, Wieland A, Nasti T, et al. Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent. Science. 2017;355(6332):1423-1427.
-
(2017)
Science
, vol.355
, Issue.6332
, pp. 1423-1427
-
-
Kamphorst, A.O.1
Wieland, A.2
Nasti, T.3
-
11
-
-
85015665428
-
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition
-
Hui E, Cheung J, Zhu J, et al. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science. 2017; 355(6332):1428-1433.
-
(2017)
Science
, vol.355
, Issue.6332
, pp. 1428-1433
-
-
Hui, E.1
Cheung, J.2
Zhu, J.3
-
12
-
-
53749094183
-
CTLA-4 control over Foxp31 regulatory T cell function
-
Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp31 regulatory T cell function. Science. 2008;322(5899): 271-275.
-
(2008)
Science
, vol.322
, Issue.5899
, pp. 271-275
-
-
Wing, K.1
Onishi, Y.2
Prieto-Martin, P.3
-
13
-
-
49249089425
-
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
-
Fife BT, Bluestone JA. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev. 2008;224(1):166-182.
-
(2008)
Immunol Rev.
, vol.224
, Issue.1
, pp. 166-182
-
-
Fife, B.T.1
Bluestone, J.A.2
-
14
-
-
84938099421
-
Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy
-
Lo B, Zhang K, Lu W, et al. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science. 2015;349(6246):436-440.
-
(2015)
Science
, vol.349
, Issue.6246
, pp. 436-440
-
-
Lo, B.1
Zhang, K.2
Lu, W.3
-
15
-
-
84984801447
-
CHAI and LATAIE: New genetic diseases of CTLA-4 checkpoint insufficiency
-
Lo B, Fritz JM, Su HC, Uzel G, Jordan MB, Lenardo MJ. CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency. Blood. 2016;128(8):1037-1042.
-
(2016)
Blood
, vol.128
, Issue.8
, pp. 1037-1042
-
-
Lo, B.1
Fritz, J.M.2
Su, H.C.3
Uzel, G.4
Jordan, M.B.5
Lenardo, M.J.6
-
16
-
-
85029765247
-
Interruption of OX40L signaling prevents costimulation blockade-resistant allograft rejection
-
Kitchens WH, Dong Y, Mathews DV, et al. Interruption of OX40L signaling prevents costimulation blockade-resistant allograft rejection. JCI Insight. 2017;2(5):e90317.
-
(2017)
JCI Insight
, vol.2
, Issue.5
, pp. e90317
-
-
Kitchens, W.H.1
Dong, Y.2
Mathews, D.V.3
-
18
-
-
0023226624
-
Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen
-
van Lier RA, Borst J, Vroom TM, et al. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol. 1987; 139(5):1589-1596.
-
(1987)
J Immunol.
, vol.139
, Issue.5
, pp. 1589-1596
-
-
Van Lier, R.A.1
Borst, J.2
Vroom, T.M.3
-
19
-
-
0024519334
-
Alternative molecular form of human T cell-specific antigen CD27 expressed upon T cell activation
-
Borst J, Sluyser C, De Vries E, Klein H, Melief CJ, Van Lier RA. Alternative molecular form of human T cell-specific antigen CD27 expressed upon T cell activation. Eur J Immunol. 1989;19(2):357-364.
-
(1989)
Eur J Immunol.
, vol.19
, Issue.2
, pp. 357-364
-
-
Borst, J.1
Sluyser, C.2
De Vries, E.3
Klein, H.4
Melief, C.J.5
Van Lier, R.A.6
-
20
-
-
33746849379
-
The crystal structure of the costimulatory OX40-OX40L complex
-
Compaan DM, Hymowitz SG. The crystal structure of the costimulatory OX40-OX40L complex. Structure. 2006;14(8):1321-1330.
-
(2006)
Structure
, vol.14
, Issue.8
, pp. 1321-1330
-
-
Compaan, D.M.1
Hymowitz, S.G.2
-
21
-
-
85009973175
-
Epitope-dependent mechanisms of CD27 neutralization revealed by X-ray crystallography
-
Obmolova G, Teplyakov A, Malia TJ, et al. Epitope-dependent mechanisms of CD27 neutralization revealed by X-ray crystallography. Mol Immunol. 2017;83:92-99.
-
(2017)
Mol Immunol.
, vol.83
, pp. 92-99
-
-
Obmolova, G.1
Teplyakov, A.2
Malia, T.J.3
-
23
-
-
84959478969
-
The CD27-CD70 pathway and pathogenesis of autoimmune disease
-
Han BK, Olsen NJ, Bottaro A. The CD27-CD70 pathway and pathogenesis of autoimmune disease. Semin Arthritis Rheum. 2016;45(4):496-501.
-
(2016)
Semin Arthritis Rheum.
, vol.45
, Issue.4
, pp. 496-501
-
-
Han, B.K.1
Olsen, N.J.2
Bottaro, A.3
-
24
-
-
0026546855
-
The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis
-
Loenen WA, De Vries E, Gravestein LA, Hintzen RQ, Van Lier RA, Borst J. The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis. Eur J Immunol. 1992;22(2): 447-455.
-
(1992)
Eur J Immunol.
, vol.22
, Issue.2
, pp. 447-455
-
-
Loenen, W.A.1
De Vries, E.2
Gravestein, L.A.3
Hintzen, R.Q.4
Van Lier, R.A.5
Borst, J.6
-
25
-
-
33847059620
-
Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells
-
Kato K, Chu P, Takahashi S, Hamada H, Kipps TJ. Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells. Exp Hematol. 2007;35(3): 434-442.
-
(2007)
Exp Hematol.
, vol.35
, Issue.3
, pp. 434-442
-
-
Kato, K.1
Chu, P.2
Takahashi, S.3
Hamada, H.4
Kipps, T.J.5
-
26
-
-
84951570153
-
T cells compete by cleaving cell surface CD27 and blocking access to CD70-bearing APCs
-
Burchill MA, Tamburini BA, Kedl RM. T cells compete by cleaving cell surface CD27 and blocking access to CD70-bearing APCs. Eur J Immunol. 2015;45(11):3140-3149.
-
(2015)
Eur J Immunol.
, vol.45
, Issue.11
, pp. 3140-3149
-
-
Burchill, M.A.1
Tamburini, B.A.2
Kedl, R.M.3
-
27
-
-
0026008939
-
A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex
-
Hintzen RQ, de Jong R, Hack CE, et al. A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J Immunol. 1991;147(1):29-35.
-
(1991)
J Immunol.
, vol.147
, Issue.1
, pp. 29-35
-
-
Hintzen, R.Q.1
De Jong, R.2
Hack, C.E.3
-
28
-
-
84990876677
-
Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis
-
Laustsen JK, Rasmussen TK, Stengaard-Pedersen K, et al. Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis. Arthritis Res Ther. 2014;16(5):474.
-
(2014)
Arthritis Res Ther.
, vol.16
, Issue.5
, pp. 474
-
-
Laustsen, J.K.1
Rasmussen, T.K.2
Stengaard-Pedersen, K.3
-
29
-
-
84923118889
-
PVHL/HIF-regulated CD70 expression is associated with infiltration of CD271 lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma
-
Ruf M, Mittmann C, Nowicka AM, et al. pVHL/HIF-regulated CD70 expression is associated with infiltration of CD271 lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma. Clin Cancer Res. 2015;21(4):889-898.
-
(2015)
Clin Cancer Res.
, vol.21
, Issue.4
, pp. 889-898
-
-
Ruf, M.1
Mittmann, C.2
Nowicka, A.M.3
-
30
-
-
84879110254
-
Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity
-
Huang J, Jochems C, Anderson AM, et al. Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity. J Immunol. 2013;190(12):6250-6258.
-
(2013)
J Immunol.
, vol.190
, Issue.12
, pp. 6250-6258
-
-
Huang, J.1
Jochems, C.2
Anderson, A.M.3
-
31
-
-
0027211704
-
Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: Implications for TNF receptor activation
-
Banner DW, D'Arcy A, Janes W, et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell. 1993;73(3):431-445.
-
(1993)
Cell
, vol.73
, Issue.3
, pp. 431-445
-
-
Banner, D.W.1
D'Arcy, A.2
Janes, W.3
-
32
-
-
42449106534
-
Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilization
-
Müller N, Wyzgol A, Münkel S, Pfizenmaier K, Wajant H. Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilization. FEBS J. 2008;275(9): 2296-2304.
-
(2008)
FEBS J.
, vol.275
, Issue.9
, pp. 2296-2304
-
-
Müller, N.1
Wyzgol, A.2
Münkel, S.3
Pfizenmaier, K.4
Wajant, H.5
-
33
-
-
68149156979
-
Trimer stabilization, oligomerization, and antibodymediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand
-
Wyzgol A, Müller N, Fick A, et al. Trimer stabilization, oligomerization, and antibodymediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand. J Immunol. 2009;183(3):1851-1861.
-
(2009)
J Immunol.
, vol.183
, Issue.3
, pp. 1851-1861
-
-
Wyzgol, A.1
Müller, N.2
Fick, A.3
-
34
-
-
84884376772
-
Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood
-
Byun M, Ma CS, Akçay A, et al. Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J Exp Med. 2013;210(9):1743-1759.
-
(2013)
J Exp Med.
, vol.210
, Issue.9
, pp. 1743-1759
-
-
Byun, M.1
Ma, C.S.2
Akçay, A.3
-
35
-
-
84941188919
-
Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency
-
Alkhairy OK, Perez-Becker R, Driessen GJ, et al. Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency. J Allergy Clin Immunol. 2015;136(3): 703-712.
-
(2015)
J Allergy Clin Immunol.
, vol.136
, Issue.3
, pp. 703-712
-
-
Alkhairy, O.K.1
Perez-Becker, R.2
Driessen, G.J.3
-
36
-
-
33746227733
-
Functional characterization of OX40 expressed on human CD81 T cells
-
Fujita T, Ukyo N, Hori T, Uchiyama T. Functional characterization of OX40 expressed on human CD81 T cells. Immunol Lett. 2006;106(1):27-33.
-
(2006)
Immunol Lett.
, vol.106
, Issue.1
, pp. 27-33
-
-
Fujita, T.1
Ukyo, N.2
Hori, T.3
Uchiyama, T.4
-
37
-
-
33646087182
-
Characterization and application of two novel monoclonal antibodies against human OX40: Costimulation of T cells and expression on tumor as well as normal gland tissues
-
Xie F, Wang Q, Chen Y, et al. Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues. Tissue Antigens. 2006;67(4):307-317.
-
(2006)
Tissue Antigens
, vol.67
, Issue.4
, pp. 307-317
-
-
Xie, F.1
Wang, Q.2
Chen, Y.3
-
38
-
-
85032859390
-
OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer
-
Montler R, Bell RB, Thalhofer C, et al. OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer. Clin Transl Immunology. 2016;5(4): e70.
-
(2016)
Clin Transl Immunology
, vol.5
, Issue.4
, pp. e70
-
-
Montler, R.1
Bell, R.B.2
Thalhofer, C.3
-
39
-
-
84982095443
-
OX401 regulatory T cells in cutaneous squamous cell carcinoma suppress effector T-cell responses and associate with metastatic potential
-
Lai C, August S, Albibas A, et al. OX401 regulatory T cells in cutaneous squamous cell carcinoma suppress effector T-cell responses and associate with metastatic potential. Clin Cancer Res. 2016;22(16):4236-4248.
-
(2016)
Clin Cancer Res.
, vol.22
, Issue.16
, pp. 4236-4248
-
-
Lai, C.1
August, S.2
Albibas, A.3
-
40
-
-
84976382144
-
Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer
-
Timperi E, Pacella I, Schinzari V, et al. Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer. OncoImmunology. 2016;5(7):e1175800.
-
(2016)
OncoImmunology
, vol.5
, Issue.7
, pp. e1175800
-
-
Timperi, E.1
Pacella, I.2
Schinzari, V.3
-
41
-
-
84922219049
-
Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue
-
Piconese S, Timperi E, Pacella I, et al. Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue. Hepatology. 2014; 60(5):1494-1507.
-
(2014)
Hepatology
, vol.60
, Issue.5
, pp. 1494-1507
-
-
Piconese, S.1
Timperi, E.2
Pacella, I.3
-
42
-
-
4444381480
-
Functional expression of CD134 by neutrophils
-
Baumann R, Yousefi S, Simon D, Russmann S, Mueller C, Simon HU. Functional expression of CD134 by neutrophils. Eur J Immunol. 2004;34(8):2268-2275.
-
(2004)
Eur J Immunol.
, vol.34
, Issue.8
, pp. 2268-2275
-
-
Baumann, R.1
Yousefi, S.2
Simon, D.3
Russmann, S.4
Mueller, C.5
Simon, H.U.6
-
43
-
-
63149163677
-
The role of TNF superfamily members in T-cell function and diseases
-
Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol. 2009;9(4):271-285.
-
(2009)
Nat Rev Immunol.
, vol.9
, Issue.4
, pp. 271-285
-
-
Croft, M.1
-
44
-
-
78650334358
-
CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human gd peripheral blood lymphocytes
-
deBarros A, Chaves-Ferreira M, d'Orey F, Ribot JC, Silva-Santos B. CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human gd peripheral blood lymphocytes. Eur J Immunol. 2011; 41(1):195-201.
-
(2011)
Eur J Immunol.
, vol.41
, Issue.1
, pp. 195-201
-
-
DeBarros, A.1
Chaves-Ferreira, M.2
D'Orey, F.3
Ribot, J.C.4
Silva-Santos, B.5
-
45
-
-
84888059493
-
The who's who of T-cell differentiation: Human memory T-cell subsets
-
Mahnke YD, Brodie TM, Sallusto F, Roederer M, Lugli E. The who's who of T-cell differentiation: human memory T-cell subsets. Eur J Immunol. 2013;43(11):2797-2809.
-
(2013)
Eur J Immunol.
, vol.43
, Issue.11
, pp. 2797-2809
-
-
Mahnke, Y.D.1
Brodie, T.M.2
Sallusto, F.3
Roederer, M.4
Lugli, E.5
-
46
-
-
49749119446
-
Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people
-
Koch S, Larbi A, Derhovanessian E, Ozcelik D, Naumova E, Pawelec G. Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing. 2008;5:6.
-
(2008)
Immun Ageing
, vol.5
, pp. 6
-
-
Koch, S.1
Larbi, A.2
Derhovanessian, E.3
Ozcelik, D.4
Naumova, E.5
Pawelec, G.6
-
47
-
-
33947687864
-
Four functionally distinct populations of human effector-memory CD81 T lymphocytes
-
Romero P, Zippelius A, Kurth I, et al. Four functionally distinct populations of human effector-memory CD81 T lymphocytes. J Immunol. 2007;178(7):4112-4119.
-
(2007)
J Immunol.
, vol.178
, Issue.7
, pp. 4112-4119
-
-
Romero, P.1
Zippelius, A.2
Kurth, I.3
-
48
-
-
44849125747
-
CD27 defines phenotypically and functionally different human NK cell subsets
-
Vossen MT, Matmati M, Hertoghs KM, et al. CD27 defines phenotypically and functionally different human NK cell subsets. J Immunol. 2008;180(6):3739-3745.
-
(2008)
J Immunol.
, vol.180
, Issue.6
, pp. 3739-3745
-
-
Vossen, M.T.1
Matmati, M.2
Hertoghs, K.M.3
-
49
-
-
0033849422
-
Regulation of CD27 expression in the course of germinal center B cell differentiation: The pivotal role of IL-10
-
Jung J, Choe J, Li L, Choi YS. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur J Immunol. 2000;30(8): 2437-2443.
-
(2000)
Eur J Immunol.
, vol.30
, Issue.8
, pp. 2437-2443
-
-
Jung, J.1
Choe, J.2
Li, L.3
Choi, Y.S.4
-
50
-
-
19344376101
-
Identification and characterization of circulating human transitional B cells
-
Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood. 2005;105(11):4390-4398.
-
(2005)
Blood
, vol.105
, Issue.11
, pp. 4390-4398
-
-
Sims, G.P.1
Ettinger, R.2
Shirota, Y.3
Yarboro, C.H.4
Illei, G.G.5
Lipsky, P.E.6
-
51
-
-
17744403449
-
CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses
-
Morimoto S, Kanno Y, Tanaka Y, et al. CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses. J Immunol. 2000;164(8): 4097-4104.
-
(2000)
J Immunol.
, vol.164
, Issue.8
, pp. 4097-4104
-
-
Morimoto, S.1
Kanno, Y.2
Tanaka, Y.3
-
52
-
-
22344432319
-
Coexpression of CD25 and CD27 identifies FoxP31 regulatory T cells in inflamed synovia
-
Ruprecht CR, Gattorno M, Ferlito F, et al. Coexpression of CD25 and CD27 identifies FoxP31 regulatory T cells in inflamed synovia. J Exp Med. 2005;201(11):1793-1803.
-
(2005)
J Exp Med.
, vol.201
, Issue.11
, pp. 1793-1803
-
-
Ruprecht, C.R.1
Gattorno, M.2
Ferlito, F.3
-
53
-
-
84899748384
-
+ tumorreactive repertoire infiltrating human tumors
-
+ tumorreactive repertoire infiltrating human tumors. J Clin Invest. 2014;124(5):2246-2259.
-
(2014)
J Clin Invest
, vol.124
, Issue.5
, pp. 2246-2259
-
-
Gros, A.1
Robbins, P.F.2
Yao, X.3
-
54
-
-
27744510433
-
TSLPactivated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand
-
Ito T, Wang YH, Duramad O, et al. TSLPactivated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med. 2005; 202(9):1213-1223.
-
(2005)
J Exp Med.
, vol.202
, Issue.9
, pp. 1213-1223
-
-
Ito, T.1
Wang, Y.H.2
Duramad, O.3
-
55
-
-
64049097483
-
Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells
-
Krause P, Bruckner M, Uermösi C, Singer E, Groettrup M, Legler DF. Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells. Blood. 2009; 113(11):2451-2460.
-
(2009)
Blood
, vol.113
, Issue.11
, pp. 2451-2460
-
-
Krause, P.1
Bruckner, M.2
Uermösi, C.3
Singer, E.4
Groettrup, M.5
Legler, D.F.6
-
56
-
-
0031572569
-
Expression and function of OX40 ligand on human dendritic cells
-
Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespesse G. Expression and function of OX40 ligand on human dendritic cells. J Immunol. 1997;159(8): 3838-3848.
-
(1997)
J Immunol.
, vol.159
, Issue.8
, pp. 3838-3848
-
-
Ohshima, Y.1
Tanaka, Y.2
Tozawa, H.3
Takahashi, Y.4
Maliszewski, C.5
Delespesse, G.6
-
57
-
-
78049524659
-
OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis
-
Karulf M, Kelly A, Weinberg AD, Gold JA. OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis. J Immunol. 2010;185(8):4856-4862.
-
(2010)
J Immunol.
, vol.185
, Issue.8
, pp. 4856-4862
-
-
Karulf, M.1
Kelly, A.2
Weinberg, A.D.3
Gold, J.A.4
-
58
-
-
66749112939
-
CD40 and OX40 ligand are differentially regulated on asthmatic airway smooth muscle
-
Krimmer DI, Loseli M, Hughes JM, et al. CD40 and OX40 ligand are differentially regulated on asthmatic airway smooth muscle. Allergy. 2009;64(7):1074-1082.
-
(2009)
Allergy
, vol.64
, Issue.7
, pp. 1074-1082
-
-
Krimmer, D.I.1
Loseli, M.2
Hughes, J.M.3
-
59
-
-
79957561768
-
- OX40Lhigh cells express IL-22 and display an LTi phenotype in human secondary lymphoid tissues
-
- OX40Lhigh cells express IL-22 and display an LTi phenotype in human secondary lymphoid tissues. Eur J Immunol. 2011;41(6):1563-1572.
-
(2011)
Eur J Immunol.
, vol.41
, Issue.6
, pp. 1563-1572
-
-
Kim, S.1
Han, S.2
Withers, D.R.3
-
60
-
-
8144221887
-
Characterization and functional study of five novel monoclonal antibodies against human OX40L highlight reverse signalling: Enhancement of IgG production of B cells and promotion of maturation of DCs
-
Wang Q, Chen Y, Ge Y, et al. Characterization and functional study of five novel monoclonal antibodies against human OX40L highlight reverse signalling: enhancement of IgG production of B cells and promotion of maturation of DCs. Tissue Antigens. 2004;64(5):566-574.
-
(2004)
Tissue Antigens
, vol.64
, Issue.5
, pp. 566-574
-
-
Wang, Q.1
Chen, Y.2
Ge, Y.3
-
61
-
-
33751119770
-
Type I interferons attenuate T cell activating functions of human mast cells by decreasing TNFalpha production and OX40 ligand expression while increasing IL-10 production
-
Fujita T, Kambe N, Uchiyama T, Hori T. Type I interferons attenuate T cell activating functions of human mast cells by decreasing TNFalpha production and OX40 ligand expression while increasing IL-10 production. J Clin Immunol. 2006;26(6):512-518.
-
(2006)
J Clin Immunol.
, vol.26
, Issue.6
, pp. 512-518
-
-
Fujita, T.1
Kambe, N.2
Uchiyama, T.3
Hori, T.4
-
62
-
-
6344254397
-
T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: Comparison of gene expression profiles between human tonsillar and lung-cultured mast cells
-
Kashiwakura J, Yokoi H, Saito H, Okayama Y. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J Immunol. 2004;173(8):5247-5257.
-
(2004)
J Immunol.
, vol.173
, Issue.8
, pp. 5247-5257
-
-
Kashiwakura, J.1
Yokoi, H.2
Saito, H.3
Okayama, Y.4
-
63
-
-
34250327453
-
Requirements for the functional expression of OX40 ligand on human activated CD41 and CD81 T cells
-
Kondo K, Okuma K, Tanaka R, et al. Requirements for the functional expression of OX40 ligand on human activated CD41 and CD81 T cells. Hum Immunol. 2007;68(7): 563-571.
-
(2007)
Hum Immunol.
, vol.68
, Issue.7
, pp. 563-571
-
-
Kondo, K.1
Okuma, K.2
Tanaka, R.3
-
64
-
-
84937641822
-
OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response
-
Jacquemin C, Schmitt N, Contin-Bordes C, et al. OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response. Immunity. 2015;42(6): 1159-1170.
-
(2015)
Immunity
, vol.42
, Issue.6
, pp. 1159-1170
-
-
Jacquemin, C.1
Schmitt, N.2
Contin-Bordes, C.3
-
65
-
-
78649830454
-
Genetic susceptibility to systemic lupus erythematosus in the genomic era
-
Deng Y, Tsao BP. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol. 2010;6(12): 683-692.
-
(2010)
Nat Rev Rheumatol.
, vol.6
, Issue.12
, pp. 683-692
-
-
Deng, Y.1
Tsao, B.P.2
-
66
-
-
79955629731
-
Irradiation enhances human T-cell function by upregulating CD70 expression on antigenpresenting cells in vitro
-
Huang J, Wang QJ, Yang S, et al. Irradiation enhances human T-cell function by upregulating CD70 expression on antigenpresenting cells in vitro. J Immunother. 2011; 34(4):327-335.
-
(2011)
J Immunother.
, vol.34
, Issue.4
, pp. 327-335
-
-
Huang, J.1
Wang, Q.J.2
Yang, S.3
-
67
-
-
84861196667
-
CD70-CD27 interaction augments CD81 T-cell activation by human epidermal Langerhans cells
-
Polak ME, Newell L, Taraban VY, et al. CD70-CD27 interaction augments CD81 T-cell activation by human epidermal Langerhans cells. J Invest Dermatol. 2012;132(6): 1636-1644.
-
(2012)
J Invest Dermatol.
, vol.132
, Issue.6
, pp. 1636-1644
-
-
Polak, M.E.1
Newell, L.2
Taraban, V.Y.3
-
68
-
-
84875426050
-
Intradermal delivery of TLR agonists in a human explant skin model: Preferential activation of migratory dendritic cells by polyribosinic-polyribocytidylic acid and peptidoglycans
-
Oosterhoff D, Heusinkveld M, Lougheed SM, et al. Intradermal delivery of TLR agonists in a human explant skin model: preferential activation of migratory dendritic cells by polyribosinic-polyribocytidylic acid and peptidoglycans. J Immunol. 2013;190(7): 3338-3345.
-
(2013)
J Immunol.
, vol.190
, Issue.7
, pp. 3338-3345
-
-
Oosterhoff, D.1
Heusinkveld, M.2
Lougheed, S.M.3
-
69
-
-
0036114917
-
Expression of tumor necrosis factor ligand superfamily costimulatory molecules CD27L, CD30L, OX40L and 4-1BBL in the heart of patients with acute myocarditis and dilated cardiomyopathy
-
Seko Y, Ishiyama S, Nishikawa T, et al. Expression of tumor necrosis factor ligand superfamily costimulatory molecules CD27L, CD30L, OX40L and 4-1BBL in the heart of patients with acute myocarditis and dilated cardiomyopathy. Cardiovasc Pathol. 2002; 11(3):166-170.
-
(2002)
Cardiovasc Pathol.
, vol.11
, Issue.3
, pp. 166-170
-
-
Seko, Y.1
Ishiyama, S.2
Nishikawa, T.3
-
70
-
-
0033571332
-
Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells
-
Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol. 1999;163(10):5358-5366.
-
(1999)
J Immunol.
, vol.163
, Issue.10
, pp. 5358-5366
-
-
Kashii, Y.1
Giorda, R.2
Herberman, R.B.3
Whiteside, T.L.4
Vujanovic, N.L.5
-
71
-
-
22144492636
-
CD701 antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa
-
Laouar A, Haridas V, Vargas D, et al. CD701 antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa. Nat Immunol. 2005;6(7): 698-706.
-
(2005)
Nat Immunol.
, vol.6
, Issue.7
, pp. 698-706
-
-
Laouar, A.1
Haridas, V.2
Vargas, D.3
-
72
-
-
0033520080
-
High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization
-
Pullen SS, Labadia ME, Ingraham RH, et al. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization. Biochemistry. 1999; 38(31):10168-10177.
-
(1999)
Biochemistry
, vol.38
, Issue.31
, pp. 10168-10177
-
-
Pullen, S.S.1
Labadia, M.E.2
Ingraham, R.H.3
-
73
-
-
0033587691
-
Crystallographic analysis of CD40 recognition and signaling by human TRAF2
-
McWhirter SM, Pullen SS, Holton JM, Crute JJ, Kehry MR, Alber T. Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc Natl Acad Sci USA. 1999;96(15):8408-8413.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, Issue.15
, pp. 8408-8413
-
-
McWhirter, S.M.1
Pullen, S.S.2
Holton, J.M.3
Crute, J.J.4
Kehry, M.R.5
Alber, T.6
-
74
-
-
0001033803
-
Structural basis for self-association and receptor recognition of human TRAF2
-
Park YC, Burkitt V, Villa AR, Tong L, Wu H. Structural basis for self-association and receptor recognition of human TRAF2. Nature. 1999;398(6727):533-538.
-
(1999)
Nature
, vol.398
, Issue.6727
, pp. 533-538
-
-
Park, Y.C.1
Burkitt, V.2
Villa, A.R.3
Tong, L.4
Wu, H.5
-
75
-
-
79952585385
-
Antigen-independent signalosome of CARMA1, PKCu, and TNF receptorassociated factor 2 (TRAF2) determines NFkB signaling in T cells
-
So T, Soroosh P, Eun SY, Altman A, Croft M. Antigen-independent signalosome of CARMA1, PKCu, and TNF receptorassociated factor 2 (TRAF2) determines NFkB signaling in T cells. Proc Natl Acad Sci USA. 2011;108(7):2903-2908.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, Issue.7
, pp. 2903-2908
-
-
So, T.1
Soroosh, P.2
Eun, S.Y.3
Altman, A.4
Croft, M.5
-
76
-
-
0032489386
-
Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation
-
Kawamata S, Hori T, Imura A, Takaori-Kondo A, Uchiyama T. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation. J Biol Chem. 1998;273(10): 5808-5814.
-
(1998)
J Biol Chem.
, vol.273
, Issue.10
, pp. 5808-5814
-
-
Kawamata, S.1
Hori, T.2
Imura, A.3
Takaori-Kondo, A.4
Uchiyama, T.5
-
77
-
-
0031962348
-
4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB
-
Arch RH, Thompson CB. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB. Mol Cell Biol. 1998;18(1):558-565.
-
(1998)
Mol Cell Biol.
, vol.18
, Issue.1
, pp. 558-565
-
-
Arch, R.H.1
Thompson, C.B.2
-
78
-
-
84866552162
-
OX40 signaling favors the induction of T(H)9 cells and airway inflammation
-
Xiao X, Balasubramanian S, Liu W, et al. OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat Immunol. 2012;13(10):981-990.
-
(2012)
Nat Immunol.
, vol.13
, Issue.10
, pp. 981-990
-
-
Xiao, X.1
Balasubramanian, S.2
Liu, W.3
-
79
-
-
79953185367
-
OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling
-
So T, Choi H, Croft M. OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling. J Immunol. 2011;186(6): 3547-3555.
-
(2011)
J Immunol.
, vol.186
, Issue.6
, pp. 3547-3555
-
-
So, T.1
Choi, H.2
Croft, M.3
-
80
-
-
0032194953
-
NF-kappaB activation in CD27 signaling: Involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27
-
Yamamoto H, Kishimoto T, Minamoto S. NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27. J Immunol. 1998; 161(9):4753-4759.
-
(1998)
J Immunol.
, vol.161
, Issue.9
, pp. 4753-4759
-
-
Yamamoto, H.1
Kishimoto, T.2
Minamoto, S.3
-
81
-
-
15444346943
-
CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun Nterminal kinase via TRAF2, TRAF5, and NFkappaB-inducing kinase
-
Akiba H, Nakano H, Nishinaka S, et al. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun Nterminal kinase via TRAF2, TRAF5, and NFkappaB-inducing kinase. J Biol Chem. 1998; 273(21):13353-13358.
-
(1998)
J Biol Chem.
, vol.273
, Issue.21
, pp. 13353-13358
-
-
Akiba, H.1
Nakano, H.2
Nishinaka, S.3
-
82
-
-
14544286868
-
TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NFkB pathway by TRAF-binding TNFRs
-
Hauer J, Püschner S, Ramakrishnan P, et al. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NFkB pathway by TRAF-binding TNFRs. Proc Natl Acad Sci USA. 2005;102(8):2874-2879.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, Issue.8
, pp. 2874-2879
-
-
Hauer, J.1
Püschner, S.2
Ramakrishnan, P.3
-
83
-
-
33645312379
-
Circuitry of nuclear factor kappaB signaling
-
Hoffmann A, Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev. 2006; 210(1):171-186.
-
(2006)
Immunol Rev.
, vol.210
, Issue.1
, pp. 171-186
-
-
Hoffmann, A.1
Baltimore, D.2
-
84
-
-
5644302162
-
Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase
-
Ramakrishnan P, Wang W, Wallach D. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. Immunity. 2004;21(4):477-489.
-
(2004)
Immunity
, vol.21
, Issue.4
, pp. 477-489
-
-
Ramakrishnan, P.1
Wang, W.2
Wallach, D.3
-
85
-
-
84055193888
-
NFkB-inducing kinase plays an essential T cell-intrinsic role in graft-versus-host disease and lethal autoimmunity in mice
-
Murray SE, Polesso F, Rowe AM, et al. NFkB-inducing kinase plays an essential T cell-intrinsic role in graft-versus-host disease and lethal autoimmunity in mice. J Clin Invest. 2011;121(12):4775-4786.
-
(2011)
J Clin Invest.
, vol.121
, Issue.12
, pp. 4775-4786
-
-
Murray, S.E.1
Polesso, F.2
Rowe, A.M.3
-
86
-
-
0033568008
-
Intracellular signaling of gp34, the OX40 ligand: Induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40
-
Matsumura Y, Hori T, Kawamata S, Imura A, Uchiyama T. Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40. J Immunol. 1999;163(6):3007-3011.
-
(1999)
J Immunol.
, vol.163
, Issue.6
, pp. 3007-3011
-
-
Matsumura, Y.1
Hori, T.2
Kawamata, S.3
Imura, A.4
Uchiyama, T.5
-
87
-
-
0033427047
-
OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection
-
Kopf M, Ruedl C, Schmitz N, et al. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. Immunity. 1999;11(6):699-708.
-
(1999)
Immunity
, vol.11
, Issue.6
, pp. 699-708
-
-
Kopf, M.1
Ruedl, C.2
Schmitz, N.3
-
88
-
-
85026304618
-
CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies
-
Al Sayed MF, Ruckstuhl CA, Hilmenyuk T, et al. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies. Blood. 2017;130(3):297-309.
-
(2017)
Blood
, vol.130
, Issue.3
, pp. 297-309
-
-
Al Sayed, M.F.1
Ruckstuhl, C.A.2
Hilmenyuk, T.3
-
89
-
-
4644324552
-
Signaling through CD70 regulates B cell activation and IgG production
-
Arens R, Nolte MA, Tesselaar K, et al. Signaling through CD70 regulates B cell activation and IgG production. J Immunol. 2004; 173(6):3901-3908.
-
(2004)
J Immunol.
, vol.173
, Issue.6
, pp. 3901-3908
-
-
Arens, R.1
Nolte, M.A.2
Tesselaar, K.3
-
90
-
-
0032871425
-
Aberrant expression and reverse signalling of CD70 on malignant B cells
-
Lens SM, Drillenburg P, den Drijver BF, et al. Aberrant expression and reverse signalling of CD70 on malignant B cells. Br J Haematol. 1999;106(2):491-503.
-
(1999)
Br J Haematol.
, vol.106
, Issue.2
, pp. 491-503
-
-
Lens, S.M.1
Drillenburg, P.2
Den Drijver, B.F.3
-
91
-
-
0028023305
-
Molecular characterization of murine and human OX40/OX40 ligand systems: Identification of a human OX40 ligand as the HTLV-1-regulated protein gp34
-
Baum PR, Gayle RB III, Ramsdell F, et al. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 1994; 13(17):3992-4001.
-
(1994)
EMBO J.
, vol.13
, Issue.17
, pp. 3992-4001
-
-
Baum, P.R.1
Gayle, R.B.2
Ramsdell, F.3
-
92
-
-
27744446078
-
Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: Comparison with B7.1 and 4-1BBL
-
Serghides L, Bukczynski J, Wen T, et al. Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL. J Immunol. 2005;175(10):6368-6377.
-
(2005)
J Immunol.
, vol.175
, Issue.10
, pp. 6368-6377
-
-
Serghides, L.1
Bukczynski, J.2
Wen, T.3
-
93
-
-
84997831536
-
Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab
-
Ramakrishna V, Sundarapandiyan K, Zhao B, Bylesjo M, Marsh HC, Keler T. Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab. J Immunother Cancer. 2015;3:37.
-
(2015)
J Immunother Cancer
, vol.3
, pp. 37
-
-
Ramakrishna, V.1
Sundarapandiyan, K.2
Zhao, B.3
Bylesjo, M.4
Marsh, H.C.5
Keler, T.6
-
94
-
-
84857800335
-
CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia
-
van Montfrans JM, Hoepelman AI, Otto S, et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol. 2012;129(3):787-793.
-
(2012)
J Allergy Clin Immunol.
, vol.129
, Issue.3
, pp. 787-793
-
-
Van Montfrans, J.M.1
Hoepelman, A.I.2
Otto, S.3
-
95
-
-
85008474195
-
Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection
-
Izawa K, Martin E, Soudais C, et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J Exp Med. 2017;214(1):73-89.
-
(2017)
J Exp Med.
, vol.214
, Issue.1
, pp. 73-89
-
-
Izawa, K.1
Martin, E.2
Soudais, C.3
-
96
-
-
85008512074
-
Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency
-
Abolhassani H, Edwards ES, Ikinciogullari A, et al. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. J Exp Med. 2017;214(1):91-106.
-
(2017)
J Exp Med.
, vol.214
, Issue.1
, pp. 91-106
-
-
Abolhassani, H.1
Edwards, E.S.2
Ikinciogullari, A.3
-
97
-
-
84948466049
-
Rationale for anti-OX40 cancer immunotherapy
-
Aspeslagh S, Postel-Vinay S, Rusakiewicz S, Soria JC, Zitvogel L, Marabelle A. Rationale for anti-OX40 cancer immunotherapy. Eur J Cancer. 2016;52:50-66.
-
(2016)
Eur J Cancer
, vol.52
, pp. 50-66
-
-
Aspeslagh, S.1
Postel-Vinay, S.2
Rusakiewicz, S.3
Soria, J.C.4
Zitvogel, L.5
Marabelle, A.6
-
98
-
-
0034651736
-
Engagement of the OX-40 receptor in vivo enhances antitumor immunity
-
Weinberg AD, Rivera MM, Prell R, et al. Engagement of the OX-40 receptor in vivo enhances antitumor immunity. J Immunol. 2000;164(4):2160-2169.
-
(2000)
J Immunol.
, vol.164
, Issue.4
, pp. 2160-2169
-
-
Weinberg, A.D.1
Rivera, M.M.2
Prell, R.3
-
99
-
-
42249097689
-
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
-
[published correction appears in J Exp Med. 2008;205(6):1505]
-
Piconese S, Valzasina B, Colombo MP. OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection [published correction appears in J Exp Med. 2008;205(6):1505]. J Exp Med. 2008;205(4): 825-839.
-
(2008)
J Exp Med.
, vol.205
, Issue.4
, pp. 825-839
-
-
Piconese, S.1
Valzasina, B.2
Colombo, M.P.3
-
100
-
-
84904038862
-
OX40 engagement depletes intratumoral Tregs via activating FcgRs, leading to antitumor efficacy
-
Bulliard Y, Jolicoeur R, Zhang J, Dranoff G, Wilson NS, Brogdon JL. OX40 engagement depletes intratumoral Tregs via activating FcgRs, leading to antitumor efficacy. Immunol Cell Biol. 2014;92(6):475-480.
-
(2014)
Immunol Cell Biol.
, vol.92
, Issue.6
, pp. 475-480
-
-
Bulliard, Y.1
Jolicoeur, R.2
Zhang, J.3
Dranoff, G.4
Wilson, N.S.5
Brogdon, J.L.6
-
101
-
-
84891275907
-
OX40 is a potent immunestimulating target in late-stage cancer patients
-
Curti BD, Kovacsovics-Bankowski M, Morris N, et al. OX40 is a potent immunestimulating target in late-stage cancer patients. Cancer Res. 2013;73(24):7189-7198.
-
(2013)
Cancer Res.
, vol.73
, Issue.24
, pp. 7189-7198
-
-
Curti, B.D.1
Kovacsovics-Bankowski, M.2
Morris, N.3
-
102
-
-
77951060733
-
OX40 is required for regulatory T cellmediated control of colitis
-
Griseri T, Asquith M, Thompson C, Powrie F. OX40 is required for regulatory T cellmediated control of colitis. J Exp Med. 2010; 207(4):699-709.
-
(2010)
J Exp Med.
, vol.207
, Issue.4
, pp. 699-709
-
-
Griseri, T.1
Asquith, M.2
Thompson, C.3
Powrie, F.4
-
103
-
-
53449091065
-
Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigenpresenting cells
-
Hippen KL, Harker-Murray P, Porter SB, et al. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigenpresenting cells. Blood. 2008;112(7): 2847-2857.
-
(2008)
Blood
, vol.112
, Issue.7
, pp. 2847-2857
-
-
Hippen, K.L.1
Harker-Murray, P.2
Porter, S.B.3
-
104
-
-
84885121967
-
Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function
-
Voo KS, Bover L, Harline ML, et al. Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function. J Immunol. 2013; 191(7):3641-3650.
-
(2013)
J Immunol.
, vol.191
, Issue.7
, pp. 3641-3650
-
-
Voo, K.S.1
Bover, L.2
Harline, M.L.3
-
105
-
-
2942661949
-
Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD81 T cell formation
-
Arens R, Schepers K, Nolte MA, et al. Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD81 T cell formation. J Exp Med. 2004;199(11):1595-1605.
-
(2004)
J Exp Med.
, vol.199
, Issue.11
, pp. 1595-1605
-
-
Arens, R.1
Schepers, K.2
Nolte, M.A.3
-
106
-
-
57449091055
-
Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD81 T cell tolerance and permits effective immunity
-
Keller AM, Schildknecht A, Xiao Y, van den Broek M, Borst J. Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD81 T cell tolerance and permits effective immunity. Immunity. 2008;29(6): 934-946.
-
(2008)
Immunity
, vol.29
, Issue.6
, pp. 934-946
-
-
Keller, A.M.1
Schildknecht, A.2
Xiao, Y.3
Van Den Broek, M.4
Borst, J.5
-
107
-
-
84908125471
-
Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients
-
de Miranda NF, Georgiou K, Chen L, et al. Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients. Blood. 2014; 124(16):2544-2553.
-
(2014)
Blood
, vol.124
, Issue.16
, pp. 2544-2553
-
-
De Miranda, N.F.1
Georgiou, K.2
Chen, L.3
-
108
-
-
84863223864
-
Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomas
-
Scholtysik R, Nagel I, Kreuz M, et al. Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomas. Int J Cancer. 2012; 131(5):E830-E835.
-
(2012)
Int J Cancer
, vol.131
, Issue.5
, pp. E830-E835
-
-
Scholtysik, R.1
Nagel, I.2
Kreuz, M.3
-
109
-
-
34249722182
-
Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation
-
French RR, Taraban VY, Crowther GR, et al. Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation. Blood. 2007;109(11): 4810-4815.
-
(2007)
Blood
, vol.109
, Issue.11
, pp. 4810-4815
-
-
French, R.R.1
Taraban, V.Y.2
Crowther, G.R.3
-
110
-
-
84965147409
-
CD27 agonism plus PD-1 blockade recapitulates CD41 T-cell help in therapeutic anticancer vaccination
-
Ahrends T, Baąbała N, Xiao Y, Yagita H, van Eenennaam H, Borst J. CD27 agonism plus PD-1 blockade recapitulates CD41 T-cell help in therapeutic anticancer vaccination. Cancer Res. 2016;76(10):2921-2931.
-
(2016)
Cancer Res.
, vol.76
, Issue.10
, pp. 2921-2931
-
-
Ahrends, T.1
Baąbała, N.2
Xiao, Y.3
Yagita, H.4
Van Eenennaam, H.5
Borst, J.6
-
111
-
-
77958059390
-
Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(1) T cells
-
Roberts DJ, Franklin NA, Kingeter LM, et al. Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(1) T cells. J Immunother. 2010;33(8):769-779.
-
(2010)
J Immunother.
, vol.33
, Issue.8
, pp. 769-779
-
-
Roberts, D.J.1
Franklin, N.A.2
Kingeter, L.M.3
-
112
-
-
9144230131
-
Cutting edge: A critical role for CD70 in CD8 T cell priming by CD40-licensed APCs
-
Taraban VY, Rowley TF, Al-Shamkhani A. Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs. J Immunol. 2004;173(11):6542-6546.
-
(2004)
J Immunol.
, vol.173
, Issue.11
, pp. 6542-6546
-
-
Taraban, V.Y.1
Rowley, T.F.2
Al-Shamkhani, A.3
-
114
-
-
33747772730
-
Requirement for CD70 in CD41 Th cell-dependent and innate receptor-mediated CD81 T cell priming
-
Taraban VY, Rowley TF, Tough DF, Al-Shamkhani A. Requirement for CD70 in CD41 Th cell-dependent and innate receptor-mediated CD81 T cell priming. J Immunol. 2006;177(5):2969-2975.
-
(2006)
J Immunol.
, vol.177
, Issue.5
, pp. 2969-2975
-
-
Taraban, V.Y.1
Rowley, T.F.2
Tough, D.F.3
Al-Shamkhani, A.4
-
115
-
-
44449156443
-
Invariant NKT cells promote CD81 cytotoxic T cell responses by inducing CD70 expression on dendritic cells
-
Taraban VY, Martin S, Attfield KE, et al. Invariant NKT cells promote CD81 cytotoxic T cell responses by inducing CD70 expression on dendritic cells. J Immunol. 2008; 180(7):4615-4620.
-
(2008)
J Immunol.
, vol.180
, Issue.7
, pp. 4615-4620
-
-
Taraban, V.Y.1
Martin, S.2
Attfield, K.E.3
-
116
-
-
84885466006
-
Agonist anti-human CD27 monoclonal antibody induces T cell activation and tumor immunity in human CD27-transgenic mice
-
He LZ, Prostak N, Thomas LJ, et al. Agonist anti-human CD27 monoclonal antibody induces T cell activation and tumor immunity in human CD27-transgenic mice. J Immunol. 2013;191(8):4174-4183.
-
(2013)
J Immunol.
, vol.191
, Issue.8
, pp. 4174-4183
-
-
He, L.Z.1
Prostak, N.2
Thomas, L.J.3
-
117
-
-
85021749676
-
Safety and activity of varlilumab, a novel and first-inclass agonist anti-CD27 antibody, in patients with advanced solid tumors
-
Burris HA, Infante JR, Ansell SM, et al. Safety and activity of varlilumab, a novel and first-inclass agonist anti-CD27 antibody, in patients with advanced solid tumors. J Clin Oncol. 2017;35(18):2028-2036.
-
(2017)
J Clin Oncol.
, vol.35
, Issue.18
, pp. 2028-2036
-
-
Burris, H.A.1
Infante, J.R.2
Ansell, S.M.3
-
118
-
-
20444374502
-
CD27/CFSEbased ex vivo selection of highly suppressive alloantigen-specific human regulatory T cells
-
Koenen HJ, Fasse E, Joosten I. CD27/CFSEbased ex vivo selection of highly suppressive alloantigen-specific human regulatory T cells. J Immunol. 2005;174(12):7573-7583.
-
(2005)
J Immunol.
, vol.174
, Issue.12
, pp. 7573-7583
-
-
Koenen, H.J.1
Fasse, E.2
Joosten, I.3
-
119
-
-
31544482746
-
Rapamycin, and not cyclosporin A, preserves the highly suppressive CD271 subset of human CD41 CD251 regulatory T cells
-
Coenen JJ, Koenen HJ, van Rijssen E, Hilbrands LB, Joosten I. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD271 subset of human CD41 CD251 regulatory T cells. Blood. 2006; 107(3):1018-1023.
-
(2006)
Blood
, vol.107
, Issue.3
, pp. 1018-1023
-
-
Coenen, J.J.1
Koenen, H.J.2
Van Rijssen, E.3
Hilbrands, L.B.4
Joosten, I.5
-
120
-
-
84863918915
-
Development of a human monoclonal antibody for potential therapy of CD27-expressing lymphoma and leukemia
-
Vitale LA, He LZ, Thomas LJ, et al. Development of a human monoclonal antibody for potential therapy of CD27-expressing lymphoma and leukemia. Clin Cancer Res. 2012; 18(14):3812-3821.
-
(2012)
Clin Cancer Res.
, vol.18
, Issue.14
, pp. 3812-3821
-
-
Vitale, L.A.1
He, L.Z.2
Thomas, L.J.3
-
121
-
-
84870352830
-
Distinctive features of the differentiated phenotype and infiltration of tumorreactive lymphocytes in clear cell renal cell carcinoma
-
Wang QJ, Hanada K, Robbins PF, Li YF, Yang JC. Distinctive features of the differentiated phenotype and infiltration of tumorreactive lymphocytes in clear cell renal cell carcinoma. Cancer Res. 2012;72(23): 6119-6129.
-
(2012)
Cancer Res.
, vol.72
, Issue.23
, pp. 6119-6129
-
-
Wang, Q.J.1
Hanada, K.2
Robbins, P.F.3
Li, Y.F.4
Yang, J.C.5
-
122
-
-
84856512553
-
CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression
-
Schürch C, Riether C, Matter MS, Tzankov A, Ochsenbein AF. CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression. J Clin Invest. 2012;122(2):624-638.
-
(2012)
J Clin Invest.
, vol.122
, Issue.2
, pp. 624-638
-
-
Schürch, C.1
Riether, C.2
Matter, M.S.3
Tzankov, A.4
Ochsenbein, A.F.5
-
123
-
-
85012240335
-
CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia
-
Riether C, Schürch CM, Bührer ED, et al. CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia. J Exp Med. 2017; 214(2):359-380.
-
(2017)
J Exp Med.
, vol.214
, Issue.2
, pp. 359-380
-
-
Riether, C.1
Schürch, C.M.2
Bührer, E.D.3
-
124
-
-
84954072873
-
First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70
-
Owonikoko TK, Hussain A, Stadler WM, et al. First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70. Cancer Chemother Pharmacol. 2016;77(1):155-162.
-
(2016)
Cancer Chemother Pharmacol.
, vol.77
, Issue.1
, pp. 155-162
-
-
Owonikoko, T.K.1
Hussain, A.2
Stadler, W.M.3
-
125
-
-
0034306979
-
Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth
-
Kjaergaard J, Tanaka J, Kim JA, Rothchild K, Weinberg A, Shu S. Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth. Cancer Res. 2000;60(19):5514-5521.
-
(2000)
Cancer Res.
, vol.60
, Issue.19
, pp. 5514-5521
-
-
Kjaergaard, J.1
Tanaka, J.2
Kim, J.A.3
Rothchild, K.4
Weinberg, A.5
Shu, S.6
-
126
-
-
84952637705
-
CD70 and IFN-1 selectively induce eomesodermin or T-bet and synergize to promote CD81 T-cell responses
-
Dong H, Franklin NA, Ritchea SB, Yagita H, Glennie MJ, Bullock TN. CD70 and IFN-1 selectively induce eomesodermin or T-bet and synergize to promote CD81 T-cell responses. Eur J Immunol. 2015;45(12):3289-3301.
-
(2015)
Eur J Immunol.
, vol.45
, Issue.12
, pp. 3289-3301
-
-
Dong, H.1
Franklin, N.A.2
Ritchea, S.B.3
Yagita, H.4
Glennie, M.J.5
Bullock, T.N.6
-
127
-
-
84919632874
-
OX40-and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD81 T cells to exit quiescence
-
Buchan S, Manzo T, Flutter B, et al. OX40-and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD81 T cells to exit quiescence. J Immunol. 2015;194(1):125-133.
-
(2015)
J Immunol.
, vol.194
, Issue.1
, pp. 125-133
-
-
Buchan, S.1
Manzo, T.2
Flutter, B.3
|